The funding comes as Eikon, run by former Merck research chief Roger Perlmutter, has started a Phase 3 trial testing one of ...

If you have concerns about your use of Depo-Provera, we would like to hear from you. Please complete the contact form on this page, send us an email at info@classlawdc.com, or give us a call at (202) ...

Telehealth provider Hims & Hers said it will tell consumers they need to seek “alternative options on the commercial dosing,” ...

Ten of 11 children born with a rare form of congenital hearing loss experienced improvements after receiving the company’s ...

The Trump administration’s plans to reduce NIH grant funding could have long-term consequences for the U.S. drug industry, ...

"Any place that gets cut, it's going to have an impact, because there's not any spare personnel at FDA,” said former agency ...

An industry source said “most, if not all” of the people at CDRH who were recently dismissed are now being asked to return.

Cavazzoni stepped down from her role as head of the FDA’s main drug review office in mid-January. She will succeed Aida ...

Mirum gained the drug, which it will sell as Ctexli for adults with cerebrotendinous xanthomatosis, in a 2023 deal with ...

The partners will test Summit’s ivonescimab alongside Pfizer’s antibody-drug conjugates in hopes of finding “potentially ...

Prescription totals for Attruby, which is locked in a closely watched commercial battle with Pfizer’s tafamidis, have more ...

Chris Gibson, Recursion’s head, cited the role small business grants played in helping his company grow its business.